List of Excipients in API celecoxib and tramadol hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing celecoxib and tramadol hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Kowa Pharmaceuticals America Inc | SEGLENTIS | celecoxib and tramadol hydrochloride | 66869-564 | CELLULOSE, MICROCRYSTALLINE | 2030-04-19 |
| Kowa Pharmaceuticals America Inc | SEGLENTIS | celecoxib and tramadol hydrochloride | 66869-564 | COPOVIDONE K25-31 | 2030-04-19 |
| Kowa Pharmaceuticals America Inc | SEGLENTIS | celecoxib and tramadol hydrochloride | 66869-564 | CROSPOVIDONE | 2030-04-19 |
| Kowa Pharmaceuticals America Inc | SEGLENTIS | celecoxib and tramadol hydrochloride | 66869-564 | MANNITOL | 2030-04-19 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for celecoxib and tramadol hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
celecoxib and tramadol hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
celecoxib and tramadol hydrochloride drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
celecoxib and tramadol hydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
celecoxib and tramadol hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
celecoxib and tramadol hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
celecoxib and tramadol hydrochloride drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
celecoxib and tramadol hydrochloride drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
celecoxib and tramadol hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
celecoxib and tramadol hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib and tramadol hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
